Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Nov 20 2025

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, KFF Health News compiles a selection of health policy studies and briefs.

CIDRAP: New Data Show Double The Risk Of Guillain-Barre Syndrome After RSV In Seniors

A large study of US adults 65 and older enrolled in Medicare finds that the risk of Guillain-Barre syndrome (GBS)—a rare autoimmune disorder in which the body's immune system attacks its own nerves—doubles in adults 65 and older infected with respiratory syncytial virus (RSV). The study, published today in Clinical Infectious Diseases, involved 452,471 patients with RSV infection requiring medical care from 2011 through 2024. (Wappes, 11/14)

CIDRAP: WHO Warns Of Rising, Worrisome Levels Of Drug-Resistant Gonorrhea 

Ceftriaxone and cefixime are the last remaining recommended treatment options for gonorrhea. But there's hope that two new antibiotics that have shown promise in clinical trials (zoliflodacin and gepotidacin) could soon provide more options. (Dall, 11/19)

Bloomberg: New Antibiotic Stokes Hope For Still Lethal TB In Study 

The new drug, developed by the not-for-profit TB Alliance, doesn’t just show promise to cut treatment times. The data indicate it has a better safety profile and the potential to defeat many strains that have become resistant to other antibiotics. Because it works more quickly, it means people spend less time coughing, sneezing or spitting, reducing the risk of contamination. (Kew, 11/19)

MedPage Today: High-Fiber Diet May Boost Immunotherapy Activity In Advanced Kidney Cancer 

Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed a high-fiber diet, a small prospective study showed. (Bankhead, 11/16)

MedPage Today: Sesame Allergy Study Compares Oral Food Challenge Methods

Oral food challenges for sesame allergy may result in more accurate results if crushed seeds or the sesame paste tahini are used instead of whole seeds, a retrospective review suggested. (Haelle, 11/18)

The Baltimore Sun: Preterm Babies Face High Blood Pressure Risk

A new study found that premature infants who spent time in a neonatal intensive care unit face higher risk for persistent high blood pressure starting from a young age. (Hille, 11/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF